Literature DB >> 27031259

Etiology, Antibiotic Resistance and Risk Factors for Neonatal Sepsis in a Large Referral Center in Zambia.

Mwila Kabwe1, John Tembo, Lophina Chilukutu, Moses Chilufya, Francis Ngulube, Chileshe Lukwesa, Monica Kapasa, Virve Enne, Hannah Wexner, Lawrence Mwananyanda, Davidson H Hamer, Sylvestor Sinyangwe, Yusuf Ahmed, Nigel Klein, Markus Maeurer, Alimuddin Zumla, Matthew Bates.   

Abstract

BACKGROUND: In sub-Saharan Africa, there is scanty data on the causes of neonatal sepsis and antimicrobial resistance among common invasive pathogens that might guide policy and practice.
METHODS: A cross-sectional observational prevalence and etiology study of neonates with suspected sepsis admitted to the neonatal intensive care unit, University Teaching Hospital, Lusaka, Zambia, between October 2013 and May 2014. Data from blood cultures and phenotypic antibiotic susceptibility testing were compared with multivariate analysis of risk factors for neonatal sepsis.
RESULTS: Of 313 neonates with suspected sepsis, 54% (170/313) were male; 20% (62/313) were born to HIV-positive mothers; 33% (103/313) had positive blood cultures, of which 85% (88/103) were early-onset sepsis. Klebsiella species was the most prevalent isolate, accounting for 75% (77/103) of cases, followed by coagulase-negative staphylococci [6% (7/103)], Staphylococcus aureus [6% (6/103)], Escherichia coli [5% (5/103)] and Candida species [5% (5/103)]. For Klebsiella species, antibiotic resistance ranged from 96%-99% for World Health Organization-recommended first-line therapy (gentamicin and ampicillin/penicillin) to 94%-97% for third-generation cephalosporins. The prevalence of culture-confirmed sepsis increased from 0 to 39% during the period December 2013 to March 2014, during which time mortality increased 29%-47%; 93% (14/15) of late-onset sepsis and 82% (37/45) of early-onset sepsis aged 4-7 days were admitted >2 days before the onset of symptoms. Culture results for only 25% (26/103) of cases were available before discharge or death. Maternal HIV infection was associated with a reduced risk of neonatal sepsis [odds ratio, 0.46 (0.23-0.93); P = 0.029].
CONCLUSIONS: Outbreaks of nosocomial multiantibiotic-resistant infections are an important cause of neonatal sepsis and associated mortality. Reduced risk of neonatal sepsis associated with maternal HIV infection is counterintuitive and requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27031259     DOI: 10.1097/INF.0000000000001154

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  35 in total

1.  Healthcare-associated Infections in Very Low Birth-weight Infants in a South African Neonatal Unit: Disease Burden, Associated Factors and Short-term Outcomes.

Authors:  Lizel Georgi Lloyd; Adrie Bekker; Mirjam M Van Weissenbruch; Angela Dramowski
Journal:  Pediatr Infect Dis J       Date:  2022-08-09       Impact factor: 3.806

2.  Contemporary Trends in Global Mortality of Sepsis Among Young Infants Less Than 90 Days: A Systematic Review and Meta-Analysis.

Authors:  Ming Ying Gan; Wen Li Lee; Bei Jun Yap; Shu Ting Tammie Seethor; Rachel G Greenberg; Jen Heng Pek; Bobby Tan; Christoph Paul Vincent Hornik; Jan Hau Lee; Shu-Ling Chong
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

3.  Admission Outcome and Antimicrobial Resistance Pattern of Bacterial Isolates among Neonates with Suspected Sepsis in Neonatal Intensive Care Unit at Dessie Comprehensive Specialized Hospital, Dessie, Northeastern Ethiopia.

Authors:  Genet Molla Fenta; Hiwot Ketema Woldemariam; Yeshi Metaferia; Abdurahaman Seid; Daniel Gebretsadik
Journal:  Interdiscip Perspect Infect Dis       Date:  2022-07-08

4.  Antibiotic regimens for late-onset neonatal sepsis.

Authors:  Steven Kwasi Korang; Sanam Safi; Chiara Nava; Gorm Greisen; Munish Gupta; Ulrik Lausten-Thomsen; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-05-08

5.  Neonatal Sepsis, Antibiotic Susceptibility Pattern, and Treatment Outcomes among Neonates Treated in Two Tertiary Care Hospitals of Yangon, Myanmar from 2017 to 2019.

Authors:  Nan Aye Thida Oo; Jeffrey K Edwards; Prajjwal Pyakurel; Pruthu Thekkur; Thae Maung Maung; Nant San San Aye; Hla Myat Nwe
Journal:  Trop Med Infect Dis       Date:  2021-04-28

6.  Antibiotic regimens for early-onset neonatal sepsis.

Authors:  Steven Kwasi Korang; Sanam Safi; Chiara Nava; Adrienne Gordon; Munish Gupta; Gorm Greisen; Ulrik Lausten-Thomsen; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-05-17

7.  High Burden of Bloodstream Infections Associated With Antimicrobial Resistance and Mortality in the Neonatal Intensive Care Unit in Pune, India.

Authors:  Julia Johnson; Matthew L Robinson; Uday C Rajput; Chhaya Valvi; Aarti Kinikar; Tushar B Parikh; Umesh Vaidya; Sudhir Malwade; Sharad Agarkhedkar; Bharat Randive; Abhay Kadam; Rachel M Smith; Matthew Westercamp; Vidya Mave; Amita Gupta; Aaron M Milstone; Yukari C Manabe
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 20.999

8.  A Systemic Review and Meta-analysis of the Leading Pathogens Causing Neonatal Sepsis in Developing Countries.

Authors:  Desalegne Amare Zelellw; Getenet Dessie; Endalkachew Worku Mengesha; Melashu Balew Shiferaw; Masresha Mela Merhaba; Solomon Emishaw
Journal:  Biomed Res Int       Date:  2021-06-05       Impact factor: 3.411

9.  Antibiogram Development in the Setting of a High Frequency of Multi-Drug Resistant Organisms at University Teaching Hospital, Lusaka, Zambia.

Authors:  Brenna M Roth; Alexandra Laps; Kaunda Yamba; Emily L Heil; J Kristie Johnson; Kristen Stafford; Lottie M Hachaambwa; Mox Kalumbi; Lloyd Mulenga; Devang M Patel; Cassidy W Claassen
Journal:  Antibiotics (Basel)       Date:  2021-06-28

10.  Clinical Characteristics, Medication Prescription Pattern, and Treatment Outcomes at the Neonatal Intensive Care Unit of a Tertiary Health-Care Facility in Ghana.

Authors:  Kwame Opare-Asamoah; George Asumeng Koffuor; Alhassan Abdul-Mumin; Baba Mohammed Sulemana; Majeed Saeed; Lawrence Quaye
Journal:  J Res Pharm Pract       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.